Keynote Speakers
Shoji Takeuchi Professor, Center For International Research on Integrative Biomedical Systems (CIBiS), Institute of Industrial Science, The University of Tokyo | 
David Weitz Professor, Harvard University | 
John Hornick Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P. | 
Elena Bulanova Head of Cell Technologies, 3D Bioprinting Solutions Russia | 
David L. Kaplan Stern Family Endowed Professor of Engineering, Professor & Chair -- Dept of Biomedical Engineering, Tufts University | 
Gabor Forgacs Professor, University of Missouri-Columbia; Scientific Founder, Organovo; CSO, Modern Meadow |
|

Jason Spector Professor of Plastic Surgery and Otolaryngology, Weill Cornell Medical College | 
Keith Murphy CEO, Organovo | 
Martin Yarmush Founding Director of the Center for Engineering in Medicine, Massachusetts General Hospital and Harvard Medical School | 
Albert Folch Professor of Bioengineering, University of Washington | 
Ibrahim Ozbolat Hartz Family Associate Professor of Engineering Science and Mechanics, The Huck Institutes of the Life Sciences, Penn State University | 
Michael Gelinsky Professor and Head, Center for Translational Bone, Joint and Soft Tissue Research, Faculty of Medicine, Technische Universität Dresden | 
Ali Khademhosseini Professor, Department of Medicine, Brigham and Women’s Hospital; Wyss Institute for Biologically Inspired Engineering, Harvard University | 
Paul Gatenholm Professor, Director of 3D Bioprinting Center, Chalmers University of Technology, Sweden; CEO, CELLHEAL AS, Norway | .png)
Lewis J. Obi Medical Director, Cell Surgical Network of Florida; Medical Director of Obi Plastic Surgery Clinic | 
Stuart Williams Director, University of Louisville | 
Ron Weiss Director, MIT Synthetic Biology Center; Professor, Massachusetts Institute of Technology (MIT) |
OverviewWelcome to the Second Annual Tissue Engineering, Biofabrication and 3D-Bioprinting Conference.
The fields of Tissue Engineering and 3D-Bioprinting are important for ultimately realizing the full potential of regenerative medicine. The potential to "3D-print" tissues and organs is gaining extensive interest and this conference brings together the academic as well as industry stakeholders in these expanding fields.
From a technology/methodology perspective, this conference addresses Tissue Engineering as well as Biofabrication and Bioprinting as we explore the latest developments in this field. Indeed, the field of Synthetic Biology currently with many ramifications and application areas is an important component of the broader Biofabrication space and therefore an entire conference track is devoted to this expanding field.
There will be a session focusing on the Clinical Translation of Tissue Engineering as means to Provide a Current State of the Landscape and Trajectory for the Future.
Posters from delegates are welcomed as a means to disseminate the most up-to-date research and commercial applications which complement the presentations from the leaders in these fields.
A co-located exhibition brings forth the technologies and commercial products in the Tissue Engineering, 3D-Bioprinting and Biofabrication fields and features companies large and small.
Agenda and Information for:
|
|
|
|
|
Corporate Sponsors
|
Media Sponsors
|
|
Networking
|
|
|
|
|
|
|